Ticker
PBYICompany Name
PUMA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Goodwill & Intangibles to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 194.92M | $ 46.26M | 23.73% |
3/31/2025 | $ 196.18M | $ 48.7M | 24.82% |
12/31/2024 | $ 213.33M | $ 51.13M | 23.97% |
9/30/2024 | $ 220.72M | $ 53.57M | 24.27% |
6/30/2024 | $ 205M | $ 56M | 27.32% |
3/31/2024 | $ 214.15M | $ 58.44M | 27.29% |
12/31/2023 | $ 230.53M | $ 60.87M | 26.41% |
9/30/2023 | $ 203.6M | $ 63.3M | 31.09% |
6/30/2023 | $ 200.49M | $ 65.74M | 32.79% |
3/31/2023 | $ 196.26M | $ 68.17M | 34.74% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for PUMA BIOTECHNOLOGY INC is calculated as follows: Intangibles [ $ 76.14M ] / Assets [ $ 261.69M ]
(=) Intang. to Assets [ 29.1% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.24K |
---|---|
min | 0% |
max | 23.21% |
average | 3.99% |
median | 0.52% |
std | 6.1% |